Am. J. Respir. Cell Mol. Biol., Volume 19, Number 6, December, 1998 910-919

Cultured Human Airway Smooth Muscle Cells Stimulated by Interleukin-1 Enhance Eosinophil Survival

Matthew P. Hallsworth, Cecilia P. C. Soh, Charles H. C. Twort, Tak H. Lee, and Stuart J. Hirst

UMDS Department of Allergy and Respiratory Medicine, Thomas Guy House, Guy's Hospital, London, United Kingdom

Airway smooth muscle may be an important cellular source of proinflammatory mediators and cytokines and may participate directly in airway inflammation. In this study we have examined whether airway smooth muscle cells could contribute to mechanisms of eosinophil accumulation by prolonging their survival. To investigate this possibility, conditioned medium from human airway smooth muscle cells stimulated with interleukin (IL)-1 was examined on the in vitro survival of highly purified human peripheral blood eosinophils. After 7 d, when cultured in control medium, less than 1 ± 0.2% of the initial eosinophil population remained viable. In contrast, culture in medium conditioned for 96 h by human airway smooth muscle cells stimulated with IL-1 (1 pg-100 ng/ml) resulted in a concentration-dependent increase in eosinophil survival. (The concentration that produced 50% of this effect was 0.03 ng/ml IL-1.) Maximum eosinophil survival occurred at 1 to 3 ng/ml IL-1. This effect was also time-dependent and was readily detected in airway smooth muscle cell-conditioned medium after just 3 h of stimulation with IL-1 (1 ng/ ml). It continued to increase before reaching a plateau around 24 h, with no decrease in activity for up to 120 h of stimulation. Conditioned medium from unstimulated airway smooth muscle cells did not enhance eosinophil survival. The survival-enhancing activity was completely inhibited (the concentration that inhibited 50% [IC₅₀] was 6.9 µg/ml) by a polyclonal goat antihuman antibody to granulocyte-macrophage colony stimulating factor (GM-CSF) (0.3-100 µg/ml), but antibodies (10-100 µg/ml) to IL-3 and IL-5, and a normal goat immunoglobulin G control had no effect on the eosinophil survival-enhancing activity. GM-CSF levels in culture medium from smooth muscle cells were markedly increased by IL-1 and were maximum at 30 ng/ml (0.037 ng/ml/10⁶ cells versus 3.561 ng/ml/10⁶ cells, unstimulated versus 30 ng/ml IL-1). The IL-1 receptor antagonist inhibited both the production of GM-CSF (IC₅₀ 19.1 ng/ml) and the eosinophil survival-enhancing (IC₅₀ 53.7 ng/ml) activity stimulated by IL-1. Release of GM-CSF elicited by IL-1 was inhibited by dexamethasone but not by indomethacin. These data indicate that cultured human airway smooth muscle cells stimulated with IL-1 support eosinophil survival through production of GM-CSF and thus may contribute to the local control of inflammatory cell accumulation in the airways.

This article has been cited by other articles:

				M. Kaur, N. S. Holden, S. M. Wilson, M. B. Sukkar, K. F. Chung, P. J. Barnes, R. Newton, and M. A. Giembycz Effect of {beta}2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L505 - L514. [Abstract] [Full Text] [PDF]

				R. M. Pascual, E. M. Carr, M. C. Seeds, M. Guo, R. A. Panettieri Jr., S. P. Peters, and R. B. Penn Regulatory features of interleukin-1beta-mediated prostaglandin E2 synthesis in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L501 - L508. [Abstract] [Full Text] [PDF]

				R. A. Panettieri Jr. Effects of Corticosteroids on Structural Cells in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 231 - 234. [Abstract] [Full Text] [PDF]

				W. T. Gerthoffer and C. A. Singer Secretory Functions of Smooth Muscle: Cytokines and Growth Factors Mol. Interv., November 1, 2002; 2(7): 447 - 456. [Abstract] [Full Text] [PDF]

				S. J. Hirst, M. P. Hallsworth, Q. Peng, and T. H. Lee Selective Induction of Eotaxin Release by Interleukin-13 or Interleukin-4 in Human Airway Smooth Muscle Cells Is Synergistic with Interleukin-1beta and Is Mediated by the Interleukin-4 Receptor alpha -Chain Am. J. Respir. Crit. Care Med., April 15, 2002; 165(8): 1161 - 1171. [Abstract] [Full Text] [PDF]

				S. Page, A. J. Ammit, J. L. Black, and C. L. Armour Human mast cell and airway smooth muscle cell interactions: implications for asthma Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1313 - L1323. [Abstract] [Full Text] [PDF]

				M. P. HALLSWORTH, L. M. MOIR, D. LAI, and S. J. HIRST Inhibitors of Mitogen-activated Protein Kinases Differentially Regulate Eosinophil-activating Cytokine Release from Human Airway Smooth Muscle Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 688 - 697. [Abstract] [Full Text] [PDF]

				S. J. Hirst, C. H. C. Twort, and T. H. Lee Differential Effects of Extracellular Matrix Proteins on Human Airway Smooth Muscle Cell Proliferation and Phenotype Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 335 - 344. [Abstract] [Full Text]

				S. McKay, S. J. Hirst, M. B.-d. Haas, J. C. de Jongste, H. C. Hoogsteden, P. R. Saxena, and H. S. Sharma Tumor Necrosis Factor-alpha Enhances mRNA Expression and Secretion of Interleukin-6 in Cultured Human Airway Smooth Muscle Cells Am. J. Respir. Cell Mol. Biol., July 1, 2000; 23(1): 103 - 111. [Abstract] [Full Text]

				C. Vancheri, M. A. Sortino, V. Tomaselli, C. Mastruzzo, F. Condorelli, G. Bellistrí, M. P. Pistorio, P. L. Canonico, and N. Crimi Different Expression of TNF-alpha Receptors and Prostaglandin E2 Production in Normal and Fibrotic Lung Fibroblasts . Potential Implications for the Evolution of the Inflammatory Process Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 628 - 634. [Abstract] [Full Text]

				J. SOLWAY What Makes the Airways Contract Abnormally? Is It Inflammation? Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S164 - 167. [Full Text] [PDF]